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審査の結果の要旨 
論文題目 
Low dose N-nitro-L-arginine Methyl Ester (L-NAME) causes salt sensitive 
hypertension via increases in activation of Na+-Cl− cotransporter (NCC). 
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Background: 
Hypertensives can be divided as salt-sensitive and salt-nonsensitive according to 
blood pressure response to salt intake. It has been hypothesized that renal dysfunction 
in salt excretion is the cause of salt-sensitive hypertension. However, recent clinical 
studies challenged this hypothesis and it is speculated that vascular dysfunction is the 
key in induction of salt sensitive hypertension. In studies with normotensives, salt-
sensitive hypertension is not necessarily accompanied by an excess circulating volume 
and is associated with inappropriate elevation of vascular resistance.  
Salt-sensitive hypertension has a high prevalence with increasing age or diabetes. 
It is well known that endothelial function is also impaired with aging and diabetes and 
nitric oxide (NO) synthesis decline. NO is not only a potent vasodilator but also 
possibly regulates sodium homeostasis at kidney tubules. High salt diet breaks the 
balance between NO and superoxide in the kidney. However, the precious mechanism 
is unclear. I speculated that NO plays a role in salt-sensitive hypertension. I blocked 
NO synthesis systemically by L-NAME and investigated the pathophysiological 
alterations both in vivo and in vitro study. 
 
Method: We have three parts in vivo and vitro experiments. 
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Results: 
In rats, short-term dietary intervention resulted in salt-sensitive hypertension. 
Under normal chow, L-NAME treatment did not elevate the BP in rats. Under a high-
salt diet, the MBP was elevated significantly from 99.5 ± 4.5 to 120.5 ± 3.0 mmHg 
within 1 wk. After implementation of a low-salt diet, BP gradually returned to normal.      
Regarding the long-term (4 weeks) effect of salt loading in mice, compatible with 
acute effect of salt loading. MBP did not change by this dose of L-NAME under normal 
diet but it significantly increased under a high-salt diet and shifted the pressure 
natriuresis curve toward the right. No significant morphological changes were observed 
in the kidney. However, significant changes of sodium and chloride excretion were 
observed after hydrochlorothiazide treatment but not after amiloride treatment, which 
was consistent with increases in p-NCC in the kidney. This highly suggested NCC, not 
ENaC was activated by L-NAME to cause salt-sensitivity.  
To confirm the importance of NCC, NCC knock out mice was used. L-NAME 
failed to induce salt-sensitivity in NCC-/- mice.  
In order to exclude effect of microcirculation in the kidney in L-NAME treated 
rodents, I investigated L-NAME effect in vitro. Firstly, I confirmed the existence of 
eNO synthases mRNA in mouse distal convoluted tubule (mDCT) cells. Secondly, p-
NCC expression was increased by L-NAME in mDCT cells in time and dose dependent 
manner. Consistent with it, NO donor—SNP decrease p-NCC in time and dose 
dependent manner. Thirdly, L-NAME increased oxidative stress and p-SPAK signaling, 
which was normalized by TEMPO, an SOD mimetic and p-SPAK inhibitor.  
To confirm the role of oxidative stress, I performed the vivo experiment again. 
After 4 weeks’ treatment, TEMPO attenuated the L-NAME-induced increases in 
superoxide, blood pressure and p-NCC expression in the C57BL/6J mice. 
 
Conclusion:  
Low dose L-NAME inappropriately and directly activate NCC via ROS-SPAK 
pathway , and finally induces salt-sensitive hypertension.  
 
  
 
Clinical perspectives 
    In the present study, systemic inhibition of NO induced salt-sensitive hypertension 
and those data could be translated into pathophysiology of aged or diabetes who show 
salt-sensitive hypertension.  
 
 
 
 
